Celsion CORP CLSN Income Statement

Celsion corp (CLSN)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Technology development and licensing revenue
500	500	500	500	500	500	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Licensing revenue
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Licensing revenue
-	-	-	-	-	-	-	-	-	-	500	-	-	500	500	500	500	500	500	500	500	500	500	500	500	500	0	0	0	-	-	-	-	2,000	0	0	0	0	0
Operating expenses:
Research and development
13,349	13,065	12,343	10,856	11,892	11,865	12,427	13,589	12,344	13,078	13,793	14,669	14,657	14,623	14,705	13,363	13,594	14,659	15,238	16,984	16,582	14,969	12,557	10,197	9,054	9,364	10,920	12,190	14,280	15,770	17,481	19,356	20,208	19,863	18,678	16,703	0	0	0
General and administrative
7,621	8,000	8,724	8,846	10,252	9,699	9,240	8,455	6,086	5,889	5,455	5,777	6,132	6,526	6,257	6,244	6,517	6,686	7,394	7,955	8,458	8,860	8,301	7,646	7,292	6,547	6,815	6,846	6,490	6,372	5,834	5,823	5,510	5,154	5,126	4,742	0	0	0
Acquisition costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
20,970	21,065	21,068	19,702	22,144	21,565	21,668	22,044	18,431	18,968	19,248	20,446	20,789	21,149	20,962	19,608	20,112	21,346	22,831	25,258	26,426	25,215	22,046	18,911	16,346	15,911	17,736	19,036	20,771	22,142	23,316	25,179	25,718	25,018	23,804	21,445	0	0	0
Loss from operations
-20,470	-20,565	-20,568	-19,202	-21,644	-21,065	-21,168	-21,544	-17,931	-18,468	-18,748	-19,946	-20,289	-20,649	-20,462	-19,108	-19,612	-20,846	-22,331	-24,758	-25,926	-24,715	-21,546	-18,411	-15,846	-15,411	-17,361	-18,786	-20,646	-22,142	-23,316	-25,179	-25,718	-23,018	-21,804	-19,445	0	0	0
Other income (expense):
(Loss) gain from change in valuation of earn-out milestone liability
18	3,189	3,152	7,181	7,031	3,630	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants issued in connection with amendment to modify GEN-1 earn-out milestone payments
-	-400	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of in-process research and development
-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) gain from change in valuation of earn-out milestone liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from valuation of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-61	61	158	158	204	30	-585	3,813	8,090	5,274	4,912	85	-4,117	-875	-580	0	-	0	0	-	-	-
(Loss) gain from valuation of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	204	30	-585	3,813	8,090	5,274	4,912	85	-4,117	-875	-580	0	-	0	0	-	-	-
Gain from change in valuation of earn-out milestone liability
-	-	-	-	-	-	-	-	-	-	1,546	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from change in valuation of earn-out milestone liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of in-process research and development
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment income
475	500	532	464	393	353	276	170	97	26	8	15	19	26	36	44	56	63	68	79	86	77	201	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Gain from valuation of common stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Investment income, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	208	240	178	174	0	0	0	0	0
Interest expense
1,382	1,393	1,395	1,060	0	-	0	0	-	91	176	337	541	722	890	1,052	1,209	1,357	1,489	1,585	1,488	1,326	1,307	1,051	965	915	691	700	534	359	195	37	138	501	0	0	0	0	0
Other income
1	0	-2	-2	-0	0	-0	-0	0	2	3	5	5	3	1	-2	-1	-1	20	19	0	-	0	0	-	-	0	0	-	-	-	0	-	-	0	-	-	-	-
Total other income (expense), net
-886	1,897	1,880	1,335	1,451	-1,237	-94	-733	-1,787	-1,933	-3,150	-2,690	-1,207	-1,403	-1,708	-920	-1,560	-1,614	-1,071	-1,319	-1,150	-779	-1,441	-1,706	2,823	7,160	4,799	4,279	-386	-4,425	-1,113	374	73	-203	-14	1,389	0	0	0
Net loss
-19,540	-16,851	-8,268	-7,447	-9,773	-11,883	-21,263	-22,278	-19,719	-20,402	-22,912	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	0	0	-	-26,568	0	0	0	-	-21,818	-18,055	0	0	0
Deemed dividend related to warrant modification
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common shareholders
-	-	-	-	-	-	-	-	-	-	-21,463	0	-	-22,053	-22,170	-20,028	-21,172	-22,461	-23,403	-26,077	-27,076	-25,494	-22,988	-20,117	-13,023	-12,852	-17,162	-19,109	-25,634	-26,568	0	0	0	-	-	-	-	-	-
Net loss per common share - Basic and diluted
-0.20	-0.11	-0.25	-0.29	-0.12	0.29	-0.26	-0.46	-0.25	1.77	-0.70	-0.70	-3.09	-5.80	-3.22	-2.63	-0.24	-0.22	-0.19	-0.27	-0.35	-0.27	-0.40	-0.38	-0.33	-0.13	-0.30	0.03	-0.55	-	-0.80	-	-0.19	-4.05	-0.25	-0.42	-0.28	-0.38	-0.22
Weighted average common shares outstanding - Basic and diluted
25,804	25,958	21,662	20,605	19,104	17,103	17,801	17,743	17,683	12,728	8,054	8,054	1,670	-19,688	1,993	1,723	23,388	23,269	23,023	20,969	19,990	22,465	17,526	17,526	16,371	-	13,601	-	9,554	-	7,475	-	33,197	-	25,150	16,366	-	-	-
Basic (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.18	-	-	-	-	-	-	-
Diluted (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.18	-	-	-	-	-	-	-
Basic (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12,087	-	-	-	33,236	-	-	-	-	-	-	-
Diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,617	-	-	-	33,236	-	-	-	-	-	-	-
Weighted average shares outstanding - basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,452	12,340	-